Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6797966
Reference Type
Journal Article
Subtype
Review
Title
Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology
Author(s)
Lyon, MS; Wosiski-Kuhn, M; Gillespie, R; Caress, J; Milligan, C
Year
2019
Is Peer Reviewed?
1
Journal
Muscle and Nerve
ISSN:
0148-639X
EISSN:
1097-4598
Volume
59
Issue
1
Page Numbers
10-22
Language
English
PMID
29979464
DOI
10.1002/mus.26289
Web of Science Id
WOS:000454609500008
Abstract
Amyotrophic lateral sclerosis (ALS) is a severely debilitating disease characterized by progressive degeneration of motor neurons. Charcot first described ALS in 18691 ; however, its pathogenesis remains unknown, and effective treatments remain elusive. It is apparent that new paradigms must be investigated to understand the effectors of ALS, including inflammation, immune responses, and the body's response to stress and injury. Herein we discuss the potential role of the immune system in ALS pathogenesis and critically review evidence from patient and animal studies. Although immune system components may indeed play a role in ALS pathogenesis, studies implicating immune cells, antibodies, and cytokines in early disease pathology are limited. We propose more focused studies that examine the role of the immune system together with characterized pathogenesis to determine when, where, and if immune and inflammatory processes are critical to disease progression, and thus worthy targets of intervention. Muscle Nerve 59:10-22, 2019.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity